RACK1 and central nervous system cancer: Overexpression of RACK1 has been strongly linked to advanced clinical stage and poor prognosis in a variety of solid cancers, and it was especially accurate as a prognostic indicator in breast cancer [26], but its prognostic value in glioma remained unclear.